cSHMT Antibodies

Santa Cruz Biotechnology offers a broad range of cSHMT monoclonal antibodies for research in cellular metabolism and folate cycle regulation. cSHMT monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cystathionine gamma-lyase (cSHMT) plays a crucial role in the transsulfuration pathway, facilitating the conversion of homocysteine to cystathionine, which is vital for maintaining cellular redox balance and synthesizing essential biomolecules. Dysregulation of cSHMT has been implicated in various diseases, including cancer and neurodegenerative disorders, highlighting its significance in both health and disease. Understanding cSHMT function and regulation provides valuable insights into metabolic disorders and potential therapeutic interventions. Researchers can utilize cSHMT monoclonal antibodies to investigate protein expression patterns across different tissues and cellular compartments. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization and quantification of cSHMT. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of metabolic pathways and their role in human health.